DeepSight Technology Appoints Scott Huennekens to Board of Directors

Huennekens brings decades of experience in building and growing medical technology companies, with expertise in image-guided therapy, surgical robotics and digital surgery.

The appointment follows DeepSight’s completion of a Series C funding round. The company is now advancing its technology, expanding partnerships and preparing for its next stage of growth.

Read More:Fintech Startup Ramp Raises $1.85 Billion in Funding

Huennekens previously served as President and CEO of Volcano Corporation, leading the company through its 2006 IPO and its acquisition by Philips in 2015.

He also led Verb Surgical, a surgical robotics company formed by Google and Johnson & Johnson, which Johnson & Johnson acquired in 2020.

Earlier, he was President and CEO of Digirad, a diagnostic imaging company. He also has extensive experience serving on the boards of public and private medical technology companies.

"Scott has helped build some of the most influential companies in interventional imaging and surgical robotics, and he understands what it takes to translate breakthrough technology into clinical adoption," said Nader Sadrzadeh, Co-Founder and CEO of DeepSight Technology.

"The next generation of interventional medicine will depend on giving physicians a more complete understanding of what is happening at the point of treatment," said Scott Huennekens. "DeepSight's approach to combining advanced sensing with imaging and AI creates a compelling opportunity to address that need.

About DeepSight Technology

Founded in 2019 by Nader Sadrzadeh, Lan Yang and Anand Chandrasekher, DeepSight Technology, Inc. develops a Physical AI platform for interventional medicine. It combines sensing technology, ultrasound imaging and artificial intelligence to help doctors perform minimally invasive procedures with greater precision and confidence and improve access to image-guided care.

Read More:CapStone Holdings Appoints Jeff Genyk as Head of Sports Ventures